Oral GLP-1s could fuel more growth Lilly has signaled regulatory filings beginning 20252026, with a global rollout that includes markets like India where tablet preference could widen access, according to Reuters
A re-examination of the relative turgidity technique for estimating water deficits in leaves
GLP-1 Drugs: The Strongest Path to Lasting Weight Loss & Improvement in Related Health Conditions September 12, 2025 By: Janet Klein, MS, RDN, CDN, CDCES Categories: Bariatric, Blog, Health & Wellness Janet Klein, MS RDN, CDN, CDCES, Bariatric Surgery and Obesity Medicine Program Director It may not be much of a surprise to hear that with the increased use of GLP-1s for weight loss, there has been a noted decline in patients undergoing bariatric surgery
These genetic variations can lead to differences in the efficiency of neural signaling pathways that control muscle activation and coordination, potentially increasing the risk of improper joint mechanics and subsequent ACL injury
Its important to consult with a knowledgeable healthcare professional, such as an endocrinologist or urologist, who specializes in TRT
This finding suggests the possibility that melanocytes activation by unknown mechanism could be the link between oral MM and MA, and it could represent more a reactive than a physiologic process
